Item 7.01 Regulation FD Disclosure
Synaptogenix, Inc. has prepared a presentation to be presented to investors on
February 17, 2021. A copy of the investor presentation is attached hereto as
In accordance with General Instruction B.2 on Form 8-K, the information set
forth in this Item 7.01 and the investor presentation attached to this report as
Exhibit 99.1, is "furnished" and shall not be deemed to be "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Exchange Act of
1934, as amended, or the Securities Act of 1933, as amended.
Item 9.01 Financial Statements and Exhibits.
99.1 Investor Presentation of Synaptogenix, Inc., dated February 17,
© Edgar Online, source Glimpses